Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Simoni, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simoni, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 3, 402-409, March 2001
© 2001 European Society of Human Reproduction and Embryology


Debate Continued

Molecular diagnosis of Y chromosome microdeletions in Europe: state-of-the-art and quality control

Manuela Simoni

1Institute of Reproductive Medicine of the University, Domagkstrasse 11, 48129 Münster, Germany. E-mail: simoni{at}uni-muenster.de

Abstract

The polymerase chain reaction (PCR) screening of microdeletions of the Y chromosome has become an important diagnostic step in the work-up of male infertility. However, there is no agreement about how this diagnosis should be performed. There are suggestions that the large variation in deletion frequency reported in the literature could be due to the various selection criteria of the patients analysed, although methodological aspects may play a role as well. As for other genetic diseases, molecular diagnosis of Y chromosome microdeletions should be controlled by adopting strict internal quality control measures and by participating in external quality assessment schemes. Such an external quality assessment project is presently being organized jointly by the European Academy of Andrology and the European Molecular Genetics Quality Network. Three preliminary trials have given a state-of-the-art picture of the diagnostic performance in various European laboratories, showing an overall rate of misdiagnosis of ~5% for both AZFb and AZFc regions, and providing data useful in the generation of guidelines for the molecular diagnosis of Y chromosome microdeletions.

Key words: assisted reproduction/azoospermia factor/male infertility/quality control/Y chromosome deletion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
C.-H. Tsai-Morris, E. Koh, Y. Sheng, Y. Maeda, R. Gutti, M. Namiki, and M. L. Dufau
Polymorphism of the GRTH/DDX25 gene in normal and infertile Japanese men: a missense mutation associated with loss of GRTH phosphorylation
Mol. Hum. Reprod., December 1, 2007; 13(12): 887 - 892.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H.-C. Lee, Y.-M. Jeong, S. H. Lee, K. Y. Cha, S.-H. Song, N. K. Kim, K. W. Lee, and S. Lee
Association study of four polymorphisms in three folate-related enzyme genes with non-obstructive male infertility
Hum. Reprod., December 1, 2006; 21(12): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. H. Vogt
AZF deletions and Y chromosomal haplogroups: history and update based on sequence
Hum. Reprod. Update, July 1, 2005; 11(4): 319 - 336.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
G. Vinci, F. Raicu, L. Popa, O. Popa, R. Cocos, and K. McElreavey
A deletion of a novel heat shock gene on the Y chromosome associated with azoospermia
Mol. Hum. Reprod., April 1, 2005; 11(4): 295 - 298.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Aittomaki, U.-B. Wennerholm, C. Bergh, A. Selbing, J. Hazekamp, and K.-G. Nygren
Safety issues in assisted reproduction technology: Should ICSI patients have genetic testing before treatment? A practical proposition to help patient information
Hum. Reprod., March 1, 2004; 19(3): 472 - 476.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. C. Raggi, P. Pinzani, A. Paradiso, M. Pazzagli, and C. Orlando
External Quality Assurance Program for PCR Amplification of Genomic DNA: An Italian Experience
Clin. Chem., May 1, 2003; 49(5): 782 - 791.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I.E. Aknin-Seifer, R.L. Touraine, H. Lejeune, J.L. Laurent, B. Lauras, and R. Levy
A simple, low cost and non-invasive method for screening Y-chromosome microdeletions in infertile men
Hum. Reprod., February 1, 2003; 18(2): 257 - 261.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Kostova, S. Rottger, W. Schempp, and J. Gromoll
Identification and characterization of the cynomolgus monkey chromodomain gene cynCDY, an orthologue of the human CDY gene family
Mol. Hum. Reprod., August 1, 2002; 8(8): 702 - 709.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
A. R. Thornhill and K. Snow
Molecular Diagnostics in Preimplantation Genetic Diagnosis
J. Mol. Diagn., February 1, 2002; 4(1): 11 - 29.
[Full Text] [PDF]


Home page
Hum ReprodHome page
G.R. Dohle, D.J.J. Halley, J.O. Van Hemel, A.M.W. van den Ouwel, M.H.E.C. Pieters, R.F.A. Weber, and L.C.P. Govaerts
Genetic risk factors in infertile men with severe oligozoospermia and azoospermia
Hum. Reprod., January 1, 2002; 17(1): 13 - 16.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.